News
Pharma company Eli Lilly is increasing its investment in its new manufacturing facilities in Limerick, Republic of Ireland. Today’s announcement of...
OctoVent, subsidiary of Hepalink Pharmaceutical Group, has entered into a license agreement with Taiwan-based Orient EuroPharma (OEP). The two...
Novo Nordisk has announced headline results from the phase 3b PIONEER PLUS trial for the safety and efficacy of once-daily oral semaglutide 25mg and...
GSK has announced promising results from part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial for Jemperli (dostarlimab) alongside standard-of-...